BB-031 in acute treatment: Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) in Acute Ischemic Stroke – The RAISE trial

BB-031 is an RNA aptamer than rapidly binds to and inactivates circulating von Willebrand Factor (vWF) and is anticipated to impede and resolve thrombus formation and embolization.